Financials
Income statement
Fiscal date | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total reported revenue | 25.9B | 25.6B | 22.6B | 18.6B |
Cost of revenue | 15.7B | 15.6B | 14.1B | 11.5B |
Gross profit | 10.2B | 10.0B | 8.5B | 7.1B |
Operating expense | ||||
Research & development | 759M | 663M | 563M | 476M |
Selling general and admin | 6.0B | 5.7B | 4.9B | 4.2B |
Other operating expenses | 295M | 228M | 74M | 64M |
Operating income | 3.4B | 3.6B | 3.1B | 2.6B |
Non operating interest income | ||||
Income | 193M | 56M | 4M | 1M |
Expense | 487M | 484M | 106M | 72M |
Other income expense | — | — | — | — |
Pretax income | 7.0B | 6.6B | 4.8B | 5.0B |
Tax provision | 805M | 744M | 665M | 604M |
Net income | 6.2B | 5.9B | 4.2B | 4.4B |
Basic EPS | 9.7 | 9.2 | 6.5 | 6.9 |
Diluted EPS | 9.6 | 9.2 | 6.5 | 6.8 |
Basic average shares | 6.2B | 6.8B | 6.8B | 6.8B |
Diluted average shares | 6.2B | 6.8B | 6.8B | 6.8B |
EBITDA | 7.5B | 7.1B | 5.6B | 5.7B |
Net income from continuing op. | 3.4B | 3.6B | 3.2B | 2.6B |
Minority interests | -30M | -7M | -6M | -4M |
Preferred stock dividends | 0 | 0 | 0 | 0 |